Related Experiment Video
Updated: Oct 8, 2025
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Exhaled Breath Condensate and Dyspnea in COPD
S Patsiris1,2, I Papanikolaou3, G Stelios3
1General Hospital of Corfu, Corfu, Greece. patsiris@hotmail.com.
Exhaled breath condensate (EBC) analysis shows potential for understanding chronic obstructive pulmonary disease (COPD) by reflecting lung inflammation and oxidative stress. Research links EBC markers to COPD symptoms like dyspnea and disease severity, warranting further investigation.
Area of Science:
- Respiratory Medicine
- Biomarker Discovery
Background:
- Chronic obstructive pulmonary disease (COPD) remains a significant challenge in respiratory medicine with unresolved pathophysiological aspects.
- Exhaled breath condensate (EBC) is a promising tool reflecting lung activity, including inflammation and oxidative stress, key processes in COPD.
Purpose of the Study:
- To explore the potential of EBC analysis in understanding COPD.
- To investigate correlations between EBC markers and clinical manifestations of COPD, particularly dyspnea and disease severity.
Main Methods:
- Analysis of biomarkers within exhaled breath condensate (EBC).
- Correlation of EBC marker levels with clinical symptoms (dyspnea) and COPD severity.
Main Results:
- Elevated levels of certain EBC markers (e.g., H₂O₂, 8-isoprostane) show a positive correlation with dyspnea in COPD patients.
- Some EBC markers exhibit ambiguous results, while others indicate a connection with increased COPD severity.
Conclusions:
- EBC analysis offers valuable insights into COPD pathophysiology, reflecting inflammation and oxidative stress.
- Further research is essential to establish robust associations between EBC markers and COPD clinical phenotypes, especially dyspnea.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...